CHMP positive on two antibiotics for skin infections
This article was originally published in Scrip
Executive Summary
Europe's CHMP has given the green light for two new antibiotics to be approved in ABSSSI (acute bacterial skin and skin structure infections): Obactiv (oritavancin) from The Medicines Company, and Cubist's Sivextro (tedizolid phosphate).